Since the new president elect Javier Miley emerged as the next president of Argentinathe variable public funds It’s like never before put into question. In line with that debate, The State declared them awarded today of the bidding processes related to vaccines. some for prevention of meningococcus and others for hepatitis A.
Just 10 days about what the new president of the Nation takes office, Javier Mileyhe National state gets ready to make a disbursement nearby at US$55 million. This sum It will be to settle two bidding processes relative to different processes related to vaccines.
One of the processes has as protagonist to the North American Pfizera company that turned out successful bidder in one of the public tenders. The same search provide to the State from his meningococcus vaccine Nimenrix. Everything will be for a total of US$47.9 million. They are in total 3 million unitswhich They were winners against the French Sanofilaboratory that had presented himself with his brand Menactra.
The tender awarded today Thursday and low the signatures of the Minister of Health of the Nation, Carla Vizzotti and of chief of staff, Agustín Rossiinvolves tetravalent conjugate vaccines against serogroups A, C, Y and W-135. The purchase had been requested by the Directorate of Control of Immunopreventable Diseases headed by Florence Bruggesser. See Official Gazette.
Pfizer will cover the demand under two presentations. Be 1.3 million of doses for infants 3 to 5 months y 1.7 million for children from 15 months to 11 years. The sum total of the purchase will be imputed charged to the Budget items of the Ministry of Health of the fiscal years 2023 and 2024.
In parallelalso a process was awarded relative to the volume acquisition of anti-hepatitis A vaccines y below the signature of the same government officials. It will be to cover in 660 mil pediatric doses and others 50 thousand, indicated for adults. In the same The national Sinergium Biotech was awarded the contract with your brand Wax pads and for a total amount of US$6.9 million. See Official Gazette // See Hepatitis A Pre-award
Other vaccines what they had entered into competition were Vaqta from North American MSD y Havrix from British GSKboth with rejected offers. The reason was that failed to meet the established admissibility requirements in the regime of Buy Argentine. See Comparative Chart.
New purchase of vaccines, meningococcus
2023-11-23 15:51:32
#PreMilei #State #awards #US55 #million #vaccines
